我們已在上線! 進一步了解
CDAK

Codiak BioSciences

已下市

CDAK已於2023年4月4日下市。

 

公司簡介: Codiak BioSciences Inc is a development-stage biopharmaceutical company focused on the development of exosome-based therapeutics for the treatment of a wide spectrum of diseases with high unmet medical need. The company have utilized engEx Platform to generate a pipeline of engineered exosomes, aimed at treating a broad range of diseases, including oncology, neuro-oncology, neurology, neuromuscular disease, infectious disease and rare disease.

員工: 53

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於CDAK的最新新聞文章。

價格圖表採用Lightweight Charts™實作